A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500mg in Healthy Male Volunteers
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
This study is a randomized, open-label, single dose, 2-way crossover study to compare the
pharmacokinetic characteristics of CKD-395 0.25/500 mg in healthy male volunteers.